Guided Therapeutics (GTHP) Other Operating Expenses (2010 - 2025)
Guided Therapeutics recorded quarterly Other Operating Expenses of $23000.0 in Q4 2025, up 4.55% quarter-over-quarter from $22000.0 in Q3 2025, and down 66.67% year-over-year from $69000.0 in Q4 2024.
Guided Therapeutics' Other Operating Expenses history runs 16 years deep, the most recent figure standing at $23000.0 for Q4 2025.
- In Q4 2025, Other Operating Expenses fell 66.67% year-over-year to $23000.0; the TTM figure through Dec 2025 stood at $169000.0 (down 41.11% YoY), while the FY2025 annual figure was $169000.0, down 41.11% from the prior year.
- Other Operating Expenses came in at $23000.0 for Q4 2025 at Guided Therapeutics, up from $22000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $76000.0 in Q3 2024 to a low of -$1000.0 in Q2 2022.
- A 5-year average of $50250.0 and a median of $52000.0 in 2022 frame the typical range for Other Operating Expenses.
- Across the five-year window, Other Operating Expenses tumbled 103.7% in 2022 and soared 6200.0% in 2023, its largest moves.
- Guided Therapeutics' Other Operating Expenses stood at $34000.0 in 2021, then surged by 52.94% to $52000.0 in 2022, then advanced by 25.0% to $65000.0 in 2023, then increased by 6.15% to $69000.0 in 2024, then sank by 66.67% to $23000.0 in 2025.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $23000.0, $22000.0, and $51000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Jun 30, 2025 | 51,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Sep 30, 2024 | 76,000.00 |
| Jun 30, 2024 | 69,000.00 |
| Mar 31, 2024 | 73,000.00 |
| Dec 31, 2023 | 65,000.00 |
| Sep 30, 2023 | 69,000.00 |
| Jun 30, 2023 | 61,000.00 |
| Mar 31, 2023 | 73,000.00 |
| Dec 31, 2022 | 52,000.00 |
| Sep 30, 2022 | 52,000.00 |
| Jun 30, 2022 | -1,000.00 |
| Mar 31, 2022 | 40,000.00 |
| Dec 31, 2021 | 34,000.00 |
| Sep 30, 2021 | 41,000.00 |
| Jun 30, 2021 | 27,000.00 |
| Mar 31, 2021 | 36,000.00 |
| Dec 31, 2020 | 32,000.00 |
| Sep 30, 2020 | 36,000.00 |
| Jun 30, 2020 | 37,000.00 |
| Mar 31, 2020 | 34,000.00 |
| Dec 31, 2019 | -4,000.00 |
| Sep 30, 2019 | 15,000.00 |
| Jun 30, 2019 | 31,000.00 |
| Mar 31, 2019 | 45,000.00 |
| Dec 31, 2018 | 39,000.00 |
| Sep 30, 2018 | 39,000.00 |
| Jun 30, 2018 | 55,000.00 |
| Mar 31, 2018 | 62,000.00 |
| Dec 31, 2017 | 58,000.00 |
| Sep 30, 2017 | 37,000.00 |
| Jun 30, 2017 | 67,000.00 |
| Mar 31, 2017 | 82,000.00 |
| Dec 31, 2016 | 98,000.00 |
| Sep 30, 2016 | 92,000.00 |
| Jun 30, 2016 | 86,000.00 |
| Mar 31, 2016 | 117,000.00 |
| Dec 31, 2015 | 176,000.00 |
| Sep 30, 2015 | 187,000.00 |
| Jun 30, 2015 | 183,000.00 |
| Mar 31, 2015 | 172,000.00 |
| Dec 31, 2014 | 402,000.00 |
| Sep 30, 2014 | 135,000.00 |
| Jun 30, 2014 | 345,000.00 |
| Mar 31, 2014 | 283,000.00 |
| Dec 31, 2013 | 291,000.00 |
| Sep 30, 2013 | 249,000.00 |
| Jun 30, 2013 | 195,000.00 |
| Mar 31, 2013 | 164,000.00 |
| Dec 31, 2012 | 153,000.00 |
| Sep 30, 2012 | 132,000.00 |
| Jun 30, 2012 | 69,000.00 |
| Mar 31, 2012 | 70,000.00 |
| Dec 31, 2011 | 1.42 Mn |
| Sep 30, 2011 | 2.37 Mn |
| Jun 30, 2011 | 71,000.00 |
| Mar 31, 2011 | 49,000.00 |
| Jun 30, 2010 | 44,000.00 |